Annette O. Walter

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 627 citations · Full text

Medicine, Oncology, Pharmacology +17

The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation

Annette O. Walter, Wolfgang Seghezzi, Wouter Korver et al. · Oncogene · 2000 · 292 citations

Life Sciences, Cell Biology, Molecular Biology +12

Apheresis therapies for NMOSD attacks

Ingo Kleiter, Anna Gahlen, Nadja Borisow et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 231 citations · Full text

Life Sciences, Immunology, Neurology +13

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

Raffit Hassan, George R. Blumenschein, Kathleen N. Moore et al. · Journal of Clinical Oncology · 2020 · 176 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

Clemens Krepler, Katrin Sproesser, Patricia Brafford et al. · Cell Reports · 2017 · 159 citations · Full text

Medicine, Cancer Biology, Oncology +17